A new approach to restore lung function and reduce antibiotic resistance Read More

Disrupting bacterial biofilms and mucus to alter the progression of pulmonary diseases

View our Pipeline

Developing a new class of
glycopolymer-based therapeutics
that target key drivers
of pulmonary decline Read More

News

November 02, 2017

Synspira Announces Data for Lead Candidate at the 31st Annual North American Cystic Fibrosis Conference

Pre-clinical results demonstrate reduction in pulmonary inflammation and infection as well as mucus clearing by SNSP113

Read More

A breath of fresh air in the treatment of lung disease.